Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development

被引:27
作者
Van der Graaf, Piet H. [1 ]
Gabrielsson, Johan [2 ]
机构
[1] Pfizer Global R&D, Pharmacokinet Dynam & Metab Dept, Sandwich, Kent, England
[2] AstraZeneca R&D Molnda, Discovery DMPK & BAC CVGI, S-43183 Molndal, Sweden
关键词
TRANSLATIONAL RESEARCH; PHARMACOLOGY;
D O I
10.4155/FMC.09.124
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1371 / 1374
页数:4
相关论文
共 24 条
[1]  
*AC MED SCI, 2007, SYST BIOL VIS ENG ME
[2]   The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics [J].
Agoram, Balaji M. ;
Martin, Steven W. ;
van der Graaf, Piet H. .
DRUG DISCOVERY TODAY, 2007, 12 (23-24) :1018-1024
[3]   Pharmacometrics: A multidisciplinary field to facilitate critical thinking in drug development and translational research settings [J].
Barrett, Jeffrey S. ;
Fossler, Michael J. ;
Cadieu, K. David ;
Gastonguay, Marc R. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (05) :632-649
[4]  
Bonate PL., 2006, PHARMACOKINETIC PHAR
[5]  
*BRIT PHARM SOC, DIPL ADV PHARM PKPD
[6]   Correct assessment of new compounds using in vivo screening models can reduce false positives [J].
Bueters, Tjerk J. H. ;
Hoogstraate, Janet ;
Visser, Sandra A. G. .
DRUG DISCOVERY TODAY, 2009, 14 (1-2) :89-94
[8]  
Danhof M., 2007, COMPREHENSIVE MED 2, P885
[9]  
Gabrielsson J., 2006, PHARMACOKINETIC PHAR
[10]   Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations [J].
Gabrielsson, Johan ;
Dolgos, Hugues ;
Gillberg, Per-Goran ;
Bredberg, Ulf ;
Benthem, Bert ;
Duker, Goran .
DRUG DISCOVERY TODAY, 2009, 14 (7-8) :358-372